Investigation of the Effect of Macitentan on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects

被引：0
|
作者：
Patricia N. Sidharta
Hartmut Dietrich
Jasper Dingemanse
机构：
[1] Actelion Pharmaceuticals Ltd,Department of Clinical Pharmacology
[2] ClinPharmCologne,undefined
[3] MEDA Manufacturing GmbH,undefined
来源：
Clinical Drug Investigation | 2014年 / 34卷
关键词：
Warfarin; Pulmonary Arterial Hypertension; International Normalise Ratio; Dabigatran; Rivaroxaban;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：545 / 552
页数：7
相关论文
共 50 条
  • [11] The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers
    R.A. Faaij
    J.M.T. van Griensven
    R.C. Schoemaker
    T. Goggin
    A. Guenzi
    J.M. Kroon
    J. Burggraaf
    A.F. Cohen
    European Journal of Clinical Pharmacology, 2001, 57 : 25 - 29
  • [12] The Effect of Aleglitazar on the Pharmacokinetics and Pharmacodynamics of S- and R-Warfarin in Healthy Male Subjects
    Sanwald-Ducray, Patricia
    Jamois, Candice
    Banken, Ludger
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2014, 63 (02) : 152 - 157
  • [13] Exenatide does not affect the pharmacokinetics and pharmacodynamics of warfarin in healthy male subjects.
    Soon, D
    Kothare, P
    Linnebjerg, H
    Park, S
    Yuen, E
    Mace, K
    Chan, C
    Wise, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P75 - P75
  • [14] Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
    Krishna, Rajesh
    Stypinski, Daria
    Ali, Melissa
    Garg, Amit
    Cote, Josee
    Maes, Andrea
    DeGroot, Bruce
    Liu, Yang
    Li, Susie
    Connolly, Sandra M.
    Wagner, John A.
    Stoch, S. Aubrey
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (01) : 116 - 124
  • [15] LACK OF A MEANINGFUL EFFECT OF ANACETRAPIB ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN IN HEALTHY SUBJECTS
    Krishna, R.
    Stypinski, D.
    Ali, M.
    Garg, A.
    Cote, J.
    Maes, A.
    DeGroot, B.
    Liu, Y.
    Connolly, S. M.
    Wagner, J. A.
    Stoch, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S10 - S10
  • [16] Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects
    Farid, N. A.
    Jakubowski, J. A.
    Payne, C. D.
    Li, Y. G.
    Jin, Y.
    Ernest, C. S., II
    Winters, K. J.
    Brandt, J. T.
    Salazar, D. E.
    Small, D. S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) : 1821 - 1829
  • [17] The Novel Antibiotic Iclaprim Had No Effect on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
    Leggewie, Stefan
    Cap, Meike
    Stengele, Eberhard
    Furdas, Silviya
    Hadvary, Paul
    Islam, Khalid
    Zeman, Paul
    Trenk, Dietmar
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 104 (06) : 514 - 514
  • [18] NILOTINIB DOES NOT INHIBIT WARFARIN PHARMACOKINETICS OR PHARMACODYNAMICS IN HEALTHY SUBJECTS
    Yin, O. Q. P.
    Gallagher, N.
    Zhao, L.
    Zhou, W.
    Golor, G.
    Schran, H.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1090 - 1090
  • [19] Evaluation of the effect of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady-state in healthy subjects
    Chappell, J.
    He, J.
    Knadler, M. P.
    Lee, D.
    Mitchell, M.
    Lobo, F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1123 - 1123
  • [20] Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
    Jiang, XM
    Williams, KM
    Liauw, WS
    Ammit, AJ
    Roufogalis, BD
    Duke, CC
    Day, RO
    McLachlan, AJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (05) : 592 - 599
12345